Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy. - Test2 - elhamkhani - TriplyDB

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.

http://www.wikidata.org/entity/Q34103169

about

IL-1β is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1β autostimulation.An experimental study of VEGF induced changes in vasoactivity in pig retinal arterioles and the influence of an anti-VEGF agent The pathogenesis of diabetic retinopathy: old concepts and new questions.Haemodynamics in microvascular complications in type 1 diabetes.Endothelins in chronic diabetic complications.Different Retinal Expression Patterns of IL-1α, IL-1β, and Their Receptors in a Rat Model of Type 1 STZ-Induced Diabetes.Pathogenesis of diabetic retinopathy and the renin-angiotensin system.Towards optimal filtering of "standard" multifocal electroretinogram (mfERG) recordings: findings in normal and diabetic subjects Changes of total antioxidant capacity and total oxidant status of aqueous humor in diabetes patients and correlations with diabetic retinopathy.Gremlin gene expression in bovine retinal pericytes exposed to elevated glucose Absence of mannose-binding lectin prevents hyperglycemic cardiovascular complications.A decrease in retinal progenitor cells is associated with early features of diabetic retinopathy in a model that combines diabetes and hypertension.Medium-chain dehydrogenases/reductases (MDR). Family characterizations including genome comparisons and active site modeling.High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1.Changes in oxidative balance in rat pericytes exposed to diabetic conditions.Effects of glucose and alpha-tocopherol on low-density lipoprotein oxidation and glycation.Dammarenediol-II Prevents VEGF-Mediated Microvascular Permeability in Diabetic Mice.An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.Role of NF-κB activation and VEGF gene polymorphisms in VEGF up regulation in non-proliferative and proliferative diabetic retinopathy.

P2860

Q34277556-AE95FA5F-56BA-4AC7-BC08-7234AD3E4134 Q34285235-EEA84EEA-284E-46CE-8BA9-19FB24727075 Q34658478-033CC4AD-35C9-4258-828C-D9CB29F7CA33 Q34804249-023708F7-0C33-4B1E-96EC-A30A8F5FF374 Q35168430-6A2F0BDE-9E77-4397-950D-AAD6D157EFCE Q35560039-1011DADE-E00D-4C5B-A969-4862D97E0E29 Q35586130-88754E14-CADC-4803-BB48-A57F66491F2B Q35591908-6051489D-5A0E-4383-9715-4C623B56BB39 Q37126890-F13E53FE-943F-416A-A64B-40542D85D4D1 Q41812757-205CF13B-42C3-439B-8BC0-9FE3E3859E74 Q42138401-EF014931-B3E0-4F64-A6FB-748F5EB95074 Q42546068-6A911BF8-2746-46BD-AC0F-C4F13E23AA2C Q44117224-31269B35-D714-4891-B1BA-5857D080735D Q44185271-67DD8823-DEBF-48AA-B6D5-88C55AA6EB1D Q44848072-DADEE7E1-39BF-4C99-A919-544EAEB226CA Q46555125-899F2D57-47DC-43C0-8995-AF01FD04A031 Q46665056-3671E85E-B103-4FCC-9CB0-E24F1326FBD2 Q46899921-A9212E03-940F-490D-8F96-D4AB0849E40F Q54273203-DE7088D3-75E1-4ECD-9ADA-1AE5FF568C46

P2860

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.

http://www.wikidata.org/entity/Q34103169

description

2000 nî lūn-bûn

@nan

2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.

@ast

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.

@en

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.

@nl

type

label

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.

@ast

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.

@en

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.

@nl

prefLabel

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.

@ast

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.

@en

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.

@nl

P1433

Q34103169-4D3C7B04-E26D-43DD-8670-878DFE6BF704

P1476

Q34103169-53F463F0-030C-4695-92CE-5C0FC9E90942

P2093

Q34103169-13DD9567-EBCC-48F3-AA42-C12A39774BA8

Q34103169-3A23C5E8-7A56-4E5B-9C20-24B25A8E55C2

Q34103169-4550F2AA-6D6B-4C9A-818C-8B27B07DF710

Q34103169-96B6BF8B-CC27-4224-9FE2-7926E6646F78

Q34103169-9764EA9D-1D5E-4051-A80C-076776AD5C49

P2860

Q34103169-01F01344-0E35-4F28-9BFE-03B1E52DF3AC

Q34103169-038E52BA-01C7-44F8-B75F-8F754DED75F0

Q34103169-045E97CA-1E9C-45F5-AC61-98AE0FBEDBF9

Q34103169-068EEA8E-6BF5-4B17-83A7-CAFD77051B39

Q34103169-075EFDD9-B37B-4E9A-B6E3-9016057A7494

Q34103169-09CE95DF-C453-4BED-B883-A4235B17CACA

Q34103169-0A9A9B80-A7C1-440D-9CE1-D8120BFA931B

Q34103169-0EEB0AAE-0E50-45B0-9DB3-16EC62273454

Q34103169-1250EE4E-57A4-4B10-A255-09A56C89500E

Q34103169-135D3C8C-8FD5-4844-AECF-D66518B1E3D6

P304

Q34103169-8431704A-7EFF-496F-868A-E694ADAFF466

P31

Q34103169-BA48C407-9011-4903-9584-2812A5BFA4AF

P356

Q34103169-80A39C97-D2D4-4748-BE2A-CD058C5B0628

P433

Q34103169-5F4D2970-4ADF-4A0F-BC83-EE347C004A23

P478

Q34103169-A6FF8563-FC5B-456D-ABAA-B532F6CF9733

P577

Q34103169-E6F8E4D4-6EBE-413B-9C21-30913ECBC5C8

P698

Q34103169-E4F4A3EF-BC76-4B21-8FCE-5730D2E4DB20

P356

1520-7560(0000)9999:9999%3C::AID-DMRR157%3E3.0.CO;2-G

P1433

Diabetes - Metabolism: Research and Reviews

P1476

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.

@en

P2093

Chakrabarti S

http://www.w3.org/2001/XMLSchema#string

Chen S

http://www.w3.org/2001/XMLSchema#string

Cukiernik M

http://www.w3.org/2001/XMLSchema#string

Evans T

http://www.w3.org/2001/XMLSchema#string

Hileeto D

http://www.w3.org/2001/XMLSchema#string

P2860

VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR)

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes

Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells

Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1

P304

393-407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1520-7560(0000)9999:9999<::AID-DMRR157>3.0.CO;2-G

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2000-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11114100

http://www.w3.org/2001/XMLSchema#string